37 related articles for article (PubMed ID: 35427563)
1. A standardized intraperitoneal Glucantime™ for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice.
Brustolin AÁ; Franzói NM; Ramos-Milaré ÁCFH; Tanoshi CA; Mota CA; Demarchi IG; Lonardoni MVC; Verzignassi Silveira TG
Exp Parasitol; 2022; 236-237():108259. PubMed ID: 35427563
[TBL] [Abstract][Full Text] [Related]
2. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
[TBL] [Abstract][Full Text] [Related]
3. N
Present C; Girão RD; Lin C; Caljon G; Van Calenbergh S; Moreira O; Ruivo LAS; Batista MM; Azevedo R; Batista DDGJ; Soeiro MNC
Parasitology; 2024 Apr; 151(5):506-513. PubMed ID: 38533610
[No Abstract] [Full Text] [Related]
4. Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Pereira IAG; Freitas CS; Câmara RSB; Jesus MM; Lage DP; Tavares GSV; Soyer TG; Ramos FF; Soares NP; Santiago SS; Martins VT; Vale DL; Pimenta BL; Ludolf F; Oliveira FM; Duarte MC; Chávez-Fumagalli MA; Costa AV; Gonçalves DU; Roatt BM; Teixeira RR; Coelho EAF
Exp Parasitol; 2024 May; 260():108743. PubMed ID: 38513973
[TBL] [Abstract][Full Text] [Related]
5. Antiparasitic Activity of Two Natural Terpenes from
Troncoso ME; Germanó MJ; Arrieta VJ; García Bustos MF; Cifuente D; Cargnelutti DE; Lozano ES
J Nat Prod; 2023 Apr; 86(4):797-803. PubMed ID: 36857574
[TBL] [Abstract][Full Text] [Related]
6. FVB/NJ strain as a mouse model for cutaneous leishmaniasis by Leishmania (L.) amazonensis.
Carrara GMP; Stolf BS
Mem Inst Oswaldo Cruz; 2024; 119():e230182. PubMed ID: 38511814
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Cutaneous Leishmaniasis Using FTIR Spectroscopy and Machine Learning: An Animal Model Study.
Pacher G; Franca T; Lacerda M; Alves NO; Piranda EM; Arruda C; Cena C
ACS Infect Dis; 2024 Feb; 10(2):467-474. PubMed ID: 38189234
[TBL] [Abstract][Full Text] [Related]
8. In vivo antileishmanial activity of Annona mucosa extracts.
Lima JPS; Pinheiro MLB; Allaman IB; Silva-Jardim I
Rev Soc Bras Med Trop; 2020; 53():e20190139. PubMed ID: 31994657
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1
Santos CC; Zhang H; Batista MM; de Oliveira GM; Demarque KC; da Silva NL; Moreira OC; Ogungbe IV; Soeiro MNC
Parasitology; 2022 Apr; 149(4):490-495. PubMed ID: 35109958
[TBL] [Abstract][Full Text] [Related]
10. Ionized alkaline water reduces injury in BALB/c mice infected with Leishmania amazonensis.
Retamiro KM; Nunes KC; Zani AP; Zani CP; Beltran LB; Silva SO; Garcia FP; Ueda-Nakamura T; Bergamasco R; Nakamura CV
PLoS One; 2023; 18(7):e0280695. PubMed ID: 37410769
[TBL] [Abstract][Full Text] [Related]
11. The absence of eosinophils is associated with early metastatic lesions in Leishmania amazonensis-infected mice.
Almeida GG; Luehring TAM; Paixão PHM; Soares RP; de Barros ALB; do Monte-Neto RL; Tafuri WL; Negrão-Corrêa DA; Gonçalves R
Mem Inst Oswaldo Cruz; 2024; 119():e220242. PubMed ID: 38198296
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis.
Peralta MF; Usseglio NA; Bracamonte ME; Guzmán ML; Olivera ME; Marco JD; Barroso PA; Carrer DC
Drug Deliv Transl Res; 2022 Jan; 12(1):180-196. PubMed ID: 33502733
[TBL] [Abstract][Full Text] [Related]
13. Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis.
Dos Santos IB; da Silva DAM; Paz FACR; Garcia DM; Carmona AK; Teixeira D; Longo-Maugéri IM; Katz S; Barbiéri CL
Front Microbiol; 2018; 9():1427. PubMed ID: 30018604
[TBL] [Abstract][Full Text] [Related]
14. Development of a topical treatment for tegumentary leishmaniasis using 8-hydroxyquinoline.
Rezende Ribeiro N; Magno Oliveira Santos L; Silva Costa S; Kei Myasaki C; Pagliara Lage D; Tamietti Martins V; Cristiane Fortes De Brito R; Chaves Freire L; Maria Ravena Severino Carvalho A; Victor Serafim Brigido B; José Alves R; Antonio Ferraz Coelho E; Mendes Roatt B; Menezes-Souza D; Costa Duarte M
Eur J Pharm Biopharm; 2024 Jun; 199():114306. PubMed ID: 38679213
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with heat-inactivated Mycobacterium bovis reduces local parasite dissemination and hepatic granuloma development in mice infected with Leishmania amazonensis.
Ferreras-Colino E; Moreno I; Gortázar C; Sevilla I; Agulló-Ros I; Domínguez L; Juste R; Risalde MA; Domínguez M
Res Vet Sci; 2023 Sep; 162():104963. PubMed ID: 37517297
[TBL] [Abstract][Full Text] [Related]
16. Combination of the Topical Photodynamic Therapy of Chloroaluminum Phthalocyanine Liposomes with Fexinidazole Oral Self-Emulsifying System as a New Strategy for Cutaneous Leishmaniasis Treatment.
Silva RA; Damasio DS; Coelho LD; de Morais-Teixeira E; Queiroz-Junior CM; Souza PE; Azevedo RB; Tedesco A; Ferreira LA; Oliveira MC; Aguiar MG
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675171
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid via Nitric Oxide Immunomodulation.
Nahrevanian H; Jalalian M; Farahmand M; Assmar M; Rastaghi AE; Sayyah M
Iran J Parasitol; 2012; 7(2):21-8. PubMed ID: 23109942
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of dendritic cells modulates immunogenesis and tolerogenesis in a neonatal model of murine cutaneous leishmaniasis.
Ponce LV; Corado J; Díaz NL; Tapia FJ
Kinetoplastid Biol Dis; 2005; 4():2. PubMed ID: 15670331
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Skin Permeation and Retention of Topical Dapsone in Murine Cutaneous Leishmaniasis Lesions.
Moreno E; Calvo A; Schwartz J; Navarro-Blasco I; González-Peñas E; Sanmartín C; Irache JM; Espuelas S
Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31766282
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of Glycerophosphocholines in the Cutaneous Lesion Caused by
Parab AR; Thomas D; Lostracco-Johnson S; Siqueira-Neto JL; McKerrow JH; Dorrestein PC; McCall LI
Pathogens; 2021 May; 10(5):. PubMed ID: 34068119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
